Abstract:The study highlight altered intersubject functional variability of brain white‐matter in major depressive disorder and its linkage with gene expression profiles and clinical applications, providing insight into the neurobiological underpinnings and potential biomarkers for diagnosis and assessment of this disorder. Major depressive disorder (MDD) is a clinically heterogeneous disorder. Its mechanism is still unknown. Although the altered intersubject variability in functional connectivity (IVFC) within gray‐matter has been reported in MDD, the alterations to IVFC within white‐matter (WM‐IVFC) remain unknown. Based on the resting‐state functional MRI data of discovery (145 MDD patients and 119 healthy controls [HCs]) and validation cohorts (54 MDD patients, and 78 HCs), we compared the WM‐IVFC between the two groups. We further assessed the meta‐analytic cognitive functions related to the alterations. The discriminant WM‐IVFC values were used to classify MDD patients and predict clinical symptoms in patients. In combination with the Allen Human Brain Atlas, transcriptome‐neuroimaging association analyses were further conducted to investigate gene expression profiles associated with WM‐IVFC alterations in MDD, followed by a set of gene functional characteristic analyses. We found extensive WM‐IVFC alterations in MDD compared to HCs, which were associated with multiple behavioral domains, including sensorimotor processes and higher‐order functions. The discriminant WM‐IVFC could not only effectively distinguish MDD patients from HCs with an area under curve ranging from 0.889 to 0.901 across three classifiers, but significantly predict depression severity (r = 0.575, p = 0.002) and suicide risk (r = 0.384, p = 0.040) in patients. Furthermore, the variability‐related genes were enriched for synapse, neuronal system, and ion channel, and predominantly expressed in excitatory and inhibitory neurons. Our results obtained good reproducibility in the validation cohort. These findings revealed intersubject functional variability changes of brain WM in MDD and its linkage with gene expression profiles, providing potential implications for understanding the high clinical heterogeneity of MDD.

Local dynamic spontaneous brain activity changes in first-episode, treatment-naïve patients with major depressive disorder and their associated gene expression profiles

565 – Abnormality of White Matter Structure and Resting State Brain Function in First-Episode, Treatment-Naive Patients with Major Depressive Disorder

Altered Resting-State Dynamic Functional Brain Networks in Major Depressive Disorder: Findings from the REST-meta-MDD Consortium

Amplitude of Low-Frequency Oscillations in First-Episode, Treatment-Naive Patients with Major Depressive Disorder: a Resting-State Functional MRI Study.

Atypical dynamic network reconfiguration and genetic mechanisms in patients with major depressive disorder

Association Analysis of Gene Expression and Brain Image Identifies Gene Signatures in Major Depression Disorder

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

Altered intersubject functional variability of brain white‐matter in major depressive disorder and its association with gene expression profiles

Altered brain network in first-episode, drug-naive patients with major depressive disorder

Brain connectivity and transcriptomic similarity inform abnormal morphometric similarity patterns in first-episode, treatment-naïve major depressive disorder

Abnormal intrinsic brain functional network dynamics in first-episode drug-naïve adolescent major depressive disorder

The ReHo analysis on the association of spontaneous regional brain activity with symptoms in first-episode depression

Abnormal neural activities in first-episode, treatment-naïve, short-illness-duration, and treatment-response patients with major depressive disorder: A resting-state fMRI study

Abnormal dynamic functional network connectivity in first-episode, drug-naïve patients with major depressive disorder

Altered spontaneous brain activity in major depressive disorder: An activation likelihood estimation meta-analysis

Connectome gradient dysfunction in major depression and its association with gene expression profiles and treatment outcomes

Dopamine Multilocus Genetic Profile, Spontaneous Activity of Left Superior Temporal Gyrus, and Early Therapeutic Effect in Major Depressive Disorder

Gene expression and brain imaging association study reveals gene signatures in major depressive disorder

Altered Brain Function in First-Episode and Recurrent Depression: A Resting-State Functional Magnetic Resonance Imaging Study

Aberrant resting-state co-activation network dynamics in major depressive disorder

State-Related Alterations of Spontaneous Neural Activity in Current and Remitted Depression Revealed by Resting-State Fmri